Welcome to our dedicated page for BIO-key International news (Ticker: BKYI), a resource for investors and traders seeking the latest updates and insights on BIO-key International stock.
BIO-key International, Inc. reports developments in identity and access management software, biometric authentication technology, and related security hardware. The company’s updates center on cloud-hosted and on-premise PortalGuard IAM, biometric-centric multi-factor authentication, Passkey:YOU, and devices such as Pocket 10 Finger Scanners and Mobile POS Pro. Customer news includes software license renewals, public-sector channel partnerships, defense deployments, and retail-bank biometric identification programs.
Financial and corporate updates also cover operating results, revenue contributions from services, license fees, and hardware, Nasdaq listing compliance, periodic-report timing, and share-structure actions such as the company’s 1-for-10 reverse stock split.
BIO-key (Nasdaq: BKYI) expects 1H 2026 revenue of approximately $5.0M, up ~50% from $3.3M in 1H 2025, driven by software license momentum and stronger hardware sales.
The company expects positive net income in 1H 2026 versus a $1.9M loss in 1H 2025, a stable cash balance near $2.7M, and specific wins including a $1.04M one-year software renewal and over $1M in hardware contracts.
BIO-key (Nasdaq: BKYI) reported 2025 revenue of $6.1M, preliminary Q1’26 revenue of $2.2M (up 37% vs Q1’25), and year-end cash of $2.7M. BIO-key cited defense, financial, and international partner traction, hardware growth, reduced SG&A, and an expectation of stronger 2026 results while noting the 2025 audit is not yet complete.
BIO-key (NASDAQ: BKYI) will host its 2025 year-end investor call on Tuesday, March 31, 2026 at 10:00 a.m. ET, with results released prior to market open. The call will be led by Mike DePasquale, Chairman & CEO, and Cecilia Welch, CFO, and will include a Q&A session.
Dial-in numbers, webcast/replay availability for three months, and audio replay details are provided for investors.
BIO-key (NASDAQ: BKYI) announced a strategic partnership with TD SYNNEX Public Sector (DLT) on March 12, 2026 to deliver identity-bound biometric and IAM solutions to U.S. federal, state, and local agencies. The collaboration integrates PortalGuard and Passkey:YOU into DLT contract vehicles to simplify procurement and support Zero Trust, phishing-resistant MFA, and compliance with CJIS, HIPAA, and NIST SP 800-171.
Key capabilities include NIST-tested, FBI-certified fingerprint biometrics, centralized SSO/IDaaS via PortalGuard, multi-factor authentication across 20+ methods, and self-service tools to reduce help-desk costs.
BIO-key (NASDAQ: BKYI) reported a new $280,000 order from a foreign defense ministry, bringing that customer's bookings to $1.14M in the past 12 months and BIO-key's total military/defense orders to over $2M in the last year.
The company highlights demand for phoneless, tokenless biometric authentication for SCIF and FME environments, support for more than 50,000 licensed users at the customer, and certifications including NIST, FBI FAP and FIPS 201.
BIO-key (NASDAQ: BKYI) secured a $1.04M one-year license renewal and expansion from a foreign retail bank on March 3, 2026, a 30% increase versus prior year. The company reports $2.7M year-end cash and expects receivables and renewals to fund growth internally. Deployment has grown from 7M enrolled clients in 2015 to over 30M today (≈300M fingerprints); the renewal anticipates 5% client enrollment growth and notes ~10,000 bank employees use the fingerprint system.
BIO-key (NASDAQ: BKYI) announced a multi-year agreement with Sociedade Interbancária de Moçambique (SIMO) on Feb. 24, 2026 to modernize identity and access security across Mozambique’s national payments network.
Integration will deploy PortalGuard IAM, PIN:You tokenless authentication and SSO via partner RunLevel, building on a May 2025 pilot and marking BIO-key’s 11th banking customer globally.
BIO-key (NASDAQ: BKYI) announced a planned Mumbai office launch and a strategic value‑added distributor partnership with Citadel Global to expand its India presence, led by BIO-key EMEA, dated Jan 29, 2026. The initiative targets large enterprises, financial institutions, and call centers and aligns with the EU–India free trade agreement to accelerate biometric IAM adoption. Citadel will provide pre-sales, deployment, training, and customer success support while BIO-key’s portfolio (PortalGuard, Passkey:YOU, Identity‑Bound Biometrics, WEB-key) will be delivered via Citadel’s local infrastructure.
BIO-key (NASDAQ: BKYI) formed a strategic partnership with Visualforma to deploy IAM and biometric authentication across Portugal’s public sector. Visualforma will lead a nationwide rollout covering more than 250 government organizations, with operational deployments already active in municipal, educational, healthcare, and a major tourist-city environment.
The program uses PortalGuard, PIN:You, WEB-key, Identity-Bound Biometrics, and certified scanners to enhance cybersecurity, regulatory compliance, and citizen-facing digital services while aligning with Cartão de Cidadão and eIDAS frameworks.
BIO-key (NASDAQ:BKYI) will present at the DealFlow Discovery investor conference at the Borgata in Atlantic City on Jan. 28–29, 2026. CEO Mike DePasquale is scheduled to present on Jan. 28 at 11:30am ET in Room 1 and will be available for 1-on-1 investor meetings during the event. Institutional investors, family offices, and high-net-worth investors may register at no cost. Presentation materials will be posted on the DealFlow Discovery website in January and registration is available online.